Given the potential keratinocyte-suppressing mechanisms described for GLP-1 RAs and the keratinocyte-stimulating effects of GLPSGLT topical, this study would have benefited from additionally examining patients with corticosteroid skin thinning, a more well-established cause of keratinocyte-suppression-related skin atrophy. This evidence concerns the gene GLP1R and skin atrophy.